References
- Allars H., Coleman M. D., Norton R. S. 1H nuclear magnetic resonance study of metronidazole metabolism by perfused rat liver. European Journal of Drug Metabolism, Disposition and Pharmacokinetics 1985; 10: 253–260
- Chenery R. J., Oldham H. G., Standring P., Norman S. J., Jennings P., Mason P. A. Antipyrine metabolism in cultured hepatocytes. Biochemical Pharmacology 1987; 36: 3077–3081
- Danhof M., Krom D. P., Breimer D. D. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment. Xenobiotica 1979; 9: 695–702
- Eichelbaum M., Sonntag B., Dengler H. J. HPLC determination of antipyrine metabolites. Pharmacology 1981; 23: 192–202
- Inaba T., Lucassen M., Kalow W. Antipyrine metabolism in the rat by three hepatic monooxygenases. Life Sciences 1980; 26: 1977–1983
- Kahn G. C., Boobis A. R., Murray S., Davies D. S. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver. Xenobiotica 1982; 12: 509–516
- La Delfa I., Zhu Q. M., Mo Z., Blaschke T. F. Fluconazole is a potent inhibitor of antipyrine metabolism in vivo in mice. Drug Metabolism and Disposition 1989; 17: 49–53
- LaRusso N. F., Lindmark D. G., Muller M. Biliary and renal excretion, hepatic metabolism, and hepatic subcellular distribution of metronidazole in the rat. Biochemical Pharmacology 1978; 27: 2247–2254
- Loft S., Poulsen H. E. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes: Influence of sex and enzyme induction and inhibition. Biochemical Pharmacology 1989; 38: 1125–1136
- Loft S., Poulsen H. E., Sonne J., Døssing M. Metronidazole clearance: a one-sample method and influencing factors. Clinical Pharmacology and Therapeutics 1988; 43: 420–428
- Loft S., Sonne J., Poulsen H. E., Petersen K. T., Jørgensen B. G., Døssing M. Inhibition and induction of metronidazole and antipyrine metabolism. European Journal of Clinical Pharmacology 1987; 32: 35–41
- Loft S., Døssing M., Poulsen H. E., Sonne J., Olesen K. L., Simonsen K., Andreasen P. B. Influence of dose and route of administration on disposition of metronidazole and its major metabolites. European Journal of Clinical Pharmacology 1986; 30: 467–473
- Lowry O. H., Rosebrough N. J., Farr A. C., Randal R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Omura T., Sato R. The carbon monoxide binding of liver microsomes. Journal of Biological Chemistry 1964; 239: 2570–2578
- Penno M. B., Vesell E. S. Monogenic control of variations in antipyrine metabolite formation. Journal of Clinical Investigations 1983; 71: 1698–1709
- Stambaugh J. E., Feo L. G., Manthei R. W. The isolation and identification of the urinary oxidative metabolites of metronidazole in man. Journal of Pharmacology and Experimental Therapeutics 1968; 161: 373–381